Anderson JW, Jones AE, Riddell-Mason S: Ten different dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats. J Nutr. 1994, 124: 78-83.
CAS
PubMed
Google Scholar
Anderson JW: Dietary fiber, complex carbohydrate and coronary artery disease. Can J Cardiol. 1995, 11: 55G-62G.
CAS
PubMed
Google Scholar
Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjønneland A, Overvad K, Martinez C, Dorronsoro M, Gonzalez CA, Key TJ, Trichopoulou A, Naska A, Vineis P, Tumino R, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Berglund G, Hallmans G, Lund E, Skeie G, Kaaks R, Riboli E: Dietary fiber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003, 361: 1496-1501. 10.1016/S0140-6736(03)13174-1.
Article
PubMed
Google Scholar
Chen CH, Sheu MT, Chen TF, Wang YC, Hou WC, Liu DZ, Chung TC, Liang YC: Suppression of endotoxin induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem Pharmacol. 2006, 72: 1001-1009. 10.1016/j.bcp.2006.07.001.
Article
CAS
PubMed
Google Scholar
Nangia-Makker P, Conklin J, Hogan V, Raz A: Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med. 2002, 8: 187-192. 10.1016/S1471-4914(02)02295-5.
Article
CAS
PubMed
Google Scholar
Kidd P: A new approach to metastasis cancer prevention: modified citrus pectin (MCP), a unique pectin that blocks cell surface lectins. Altern Med Rev. 1996, 1: 4-10.
Google Scholar
Olano-Martin E, Rimbach GH, Gibson GR, Rastall RA: Pectin and pectic-oligosaccharides induce apoptosis in in vivo human colonic adenocarcinoma cells. Anticancer Res. 2003, 23: 341-346.
CAS
PubMed
Google Scholar
Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A: Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Ins. 2002, 94: 1854-1862.
Article
CAS
Google Scholar
Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI: Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis. 2003, 6: 301-304. 10.1038/sj.pcan.4500679.
Article
CAS
PubMed
Google Scholar
Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A: Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995, 87: 348-353. 10.1093/jnci/87.5.348.
Article
CAS
PubMed
Google Scholar
Yan J, Katz A: PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and- independent prostate cancer cells. Integr Cancer Ther. 2010, 9: 197-203. 10.1177/1534735410369672.
Article
CAS
PubMed
Google Scholar
Glinsky VV, Raz A: Modified citrus pectin anti-metastatic properties: one bullet multiple targets. Carbohydr Res. 2009, 14: 1788-91.
Article
Google Scholar
Ye MB, Lim BO: Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice. J Agric Food Chem. 2010,
Google Scholar
Sherry CL, Kim SS, Dilger RN, Bauer LL, Moon ML, Tapping RI, Fahey GC, Tappenden KA, Freund GG: Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav Immun. 2010, 24: 631-40. 10.1016/j.bbi.2010.01.015.
Article
CAS
PubMed
PubMed Central
Google Scholar
Salman H, Bergman M, Djaldetti M, Orlin J, Bessler H: Citrus pectin affects cytokine production by human peripheral blood mononuclear cells. Biomed Pharmacother. 2008, 62: 579-82. 10.1016/j.biopha.2008.07.058.
Article
CAS
PubMed
Google Scholar
Liu Y, Ahmad H, Luo Y, Gardiner DT, Gunasekera RS, McKeehan WL, Patil BS: Citrus pectin: characterization and inhibitory effect on fibroblast growth factor - receptor interaction. J Ag Food Chem. 2001, 49: 3051-3057. 10.1021/jf001020n.
Article
CAS
Google Scholar
Matsumoto T, Moriya M, Sakurai MH, Kiyohara H, Tabuchi Y, Yamada H: Stimulatory effect of a pectic polysaccharide from a medicinal herb, the roots of Bupleurm falcatum L., on G-CSF secretion from intestinal epithelial cells. Int Immunopharmacol. 2008, 8: 581-588. 10.1016/j.intimp.2008.01.006.
Article
CAS
PubMed
Google Scholar
Inngjerdingen M, Inngjerdingen KT, Patel TR, Allen S, Chen X, Rolstad B, Morris GA, Harding SE, Michaelsen TE, Diallo D, Paulsen BS: Pectic polysaccharides from Biophytum petersianum Klotzsch, and their activation of macrophages and dendritic cells. Glycobiology. 2008, 18: 1074-84. 10.1093/glycob/cwn090.
Article
CAS
PubMed
Google Scholar
Vos AP, Haarman M, van Ginkel JW, Knol J, Garssen J, Stahl B, Boehm G, M'Rabet L: Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol. 2007, 18: 304-312. 10.1111/j.1399-3038.2007.00515.x.
Article
PubMed
Google Scholar
Vos AP, van Esch BC, Stahl B, M'Rabet L, Folkerts G, Nijkamp FP, Garssen J: Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int Immunopharmacol. 2007, 7: 1582-1587. 10.1016/j.intimp.2007.07.024.
Article
CAS
PubMed
Google Scholar
Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL: Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis. 2005, 26: 309-318.
Article
CAS
PubMed
Google Scholar
Johnson KD, Glinskii OV, Mossine VV, Turk JR, Mawhinney TP, Anthony DC, Henry CJ, Huxley VH, Glinsky GV, Pienta KJ, Raz A, Glinsky VV: Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia. 2007, 9: 662-670. 10.1593/neo.07433.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogensis. Am J Pathol. 2000, 156: 899-909. 10.1016/S0002-9440(10)64959-0.
Article
CAS
PubMed
PubMed Central
Google Scholar
Inohara H, Raz A: Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J. 1994, 11: 527-532. 10.1007/BF00731303.
Article
CAS
PubMed
Google Scholar
Gunning AP, Bongaerts RJ, Morris VJ: Recognition of galactan components of pectin by galectin-3. FASEB J. 2009, 23: 415-424.
Article
CAS
PubMed
Google Scholar
Platt D, Raz A: Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst. 1992, 84: 438-442. 10.1093/jnci/84.6.438.
Article
CAS
PubMed
Google Scholar
Glinsky VV, Huflejt M, Glinsky G, Deutscher S, Quinn T: Effects of Thomsen-Friendenreich antigen-specific peptide p-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res. 2000, 60: 2584-2588.
CAS
PubMed
Google Scholar
Liu HY, Huang ZL, Yang GH, Lu WQ, Yu NR: Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. World J Gastroenterol. 2008, 14: 7386-7391. 10.3748/wjg.14.7386.
Article
CAS
PubMed
PubMed Central
Google Scholar
Azemar M, Hildenbrand B, Haering B, Heim ME, Unger C: Clinical benefit in patients with advanced solid tumors treated with modified citrus pectin: a prospective pilot study. Clin Med: Oncol. 2007, 1: 73-80.
CAS
Google Scholar
Eliaz I, Hotchkiss A, Fishman M, Rode D: The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006, 20: 859-864. 10.1002/ptr.1953.
Article
CAS
PubMed
Google Scholar
Zhao ZY, Liang L, Fan X, Yu Z, Hotchkiss AT, Wilk BJ, Eliaz I: The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels. Altern Ther Health Med. 2008, 14: 34-38.
PubMed
Google Scholar
Kolatsi-Joannou M, Price KL, Winyard PJ, Long DA: Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury. PLoS One. 2011, 6: e18683-10.1371/journal.pone.0018683.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lim LC, Fiordalisi MN, Mantell JL, Schmitz JL, Folds JD: A whole-blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry. Clin Diagn Lab Immunol. 1998, 5: 392-398.
CAS
PubMed
PubMed Central
Google Scholar
Liu L, Chahroudi A, Silvestri G, Wernett ME, Kaiser WJ, Safrit JT, Komoriya A, Altman JD, Packard BZ, Feinberg MB: Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase molecules. Nat Med. 2000, 8: 185-189.
Article
Google Scholar
Jerome KR, Sloan DD, Aubert M: Measuring T-cell mediated cytotoxicity using antibody to activated caspases. Nat Med. 2002, 9: 4-5. 10.1038/nsb0102-4.
Article
Google Scholar
Hotchkiss AT, Hicks KB: Analysis of pectate lyase-generated oligogalacturonic acids by high-performance anion-exchange chromatography and pulsed amperometric detection. Carbohydr Res. 2003, 247: 1-7.
Article
Google Scholar
Robertson MJ, Ritz J: Biology and clinical relevance of natural killer cells. Blood. 1990, 76: 2421-2438.
CAS
PubMed
Google Scholar
Takeda K, Okumura K: CAM and NK Cells. eCAM. 2010, 1: 17-27.
Google Scholar
Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V: Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: Effect on intestinal flora, stool characteristics, and pH. J Pediatr Gasteroentero Nutrit. 2005, 41: 186-190. 10.1097/01.mpg.0000172747.64103.d7.
Article
CAS
Google Scholar